The Management of Invasive Fungal Infections: What to Consider in Empirical Treatment?

Basit Öğe Kaydı
dc.contributor.authorDemirkan, Fatih
dc.contributor.authorSaydam, Güray
dc.contributor.authorArda, Bilgin
dc.contributor.authorOzcan, M. Ali
dc.date.accessioned2019-10-27T21:42:43Z
dc.date.available2019-10-27T21:42:43Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.description.abstractInvasive fungal infections (IFI) are a major cause of morbidity and mortality in immunocompromised patients. Candida and Aspergillus are the most common fungi that lead to IFI. While invasive Candida infections are most commonly seen in patients in intensive care units (ICUs) and very low birth weight infants, aspergillosis is most frequent in immunocompromised patients, especially in patients with hematological malignancies and in those undergoing hematopoietic stem cell transplantation (HSCT). Empirical treatment should be considered in all high-risk patients with hematological malignancies suspected of having IFIs.en_US
dc.identifier.doi10.4999/uhod.13033
dc.identifier.endpage12en_US
dc.identifier.issn1306-133X
dc.identifier.issue3en_US
dc.identifier.startpage1en_US
dc.identifier.urihttps://doi.org/10.4999/uhod.13033
dc.identifier.urihttps://hdl.handle.net/11454/46950
dc.identifier.volume23en_US
dc.identifier.wosWOS:000325121600001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAkad Doktorlar Yayinevien_US
dc.relation.ispartofUhod-Uluslararasi Hematoloji-Onkoloji Dergisien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectInvasive fungal infectionen_US
dc.subjectEmpirical antifungal therapyen_US
dc.titleThe Management of Invasive Fungal Infections: What to Consider in Empirical Treatment?en_US
dc.typeReview Articleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu